HOF-based catalytic platform combining sonodynamic therapy and bioorthogonal activation of immunosuppression reversal for cancer therapy

Combination cancer immunotherapy based on ultrasound (US) and immunotherapy shows potent anti-cancer efficacy. However, most sonosensitizers produce ROS with low efficiency under US. Chemotherapy-induced immunogenic cell death (ICD) is also plagued by